Buddy/Support Worker – Hackney Term Time: 16 hours per week Non-Term Time: 32 hours per week £17.00 - £18.00 per hour Are you looking for a new role which will be fulfilling and fundamental in enabling a young Client to develop and gr...
organisation in the Teesside area to assist them in their recruitment for a HR Administrator to join the team on a permanent basis.... Background Reporting into the HR Manager this role is ideal for an HR Administrator or HR Assistant looking for a new challenge...
of HR is a key leadership role in the UK & Ireland business. Being genuinely people centred in how we work and operate... and as an admired people brand. What will my accountabilities be? This role leads leaders across HR Business Partnership (operations...
Working closely with the HR Employee Relations Manager, the HR Business Partners and the HR Services team to provide proactive... and commercial HR advice and guidance to the business to assist them in delivering their overall business strategy. Key...
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »
V-Mart acquired Limeroad in FY23 to push its omnichannel strategy, but has been cutting costs to reduce Limeroad’s losses of late..Limeroad’s Ebitda loss in FY24 stood at ₹71.6 crore and V-Mart expects the FY25 loss to be 40-50% of that. Continue Reading »